Laser Photonics Corporation ,a leading global developer of industrial laser systems for cleaning and other material processing applications, joined by its recently acquired subsidiary, Control Micro Systems, Inc. (CMS), announced the expansion of its tablet laser drilling technology development program targeting the pharmaceutical and medical technology market.
Tablet laser drilling is a proven, economically viable way to create sub-millimeter apertures in pharmaceutical tablets. This method plays a key role in osmotic pump time-release drug delivery systems, which provide many health benefits like decreasing dosing frequencies, maintaining consistent drug levels in the body over a specific period and enabling customized delivery profiles.
For LPC, established as a trusted provider of industrial laser equipment, pharmaceutical and medical technologies is a new sector of focus. Supplemented by CMS expertise, LPC is dedicating resources to research and development in this sector in accordance with its broad diversification strategy, poised to contribute to growing shareholder value and foster greater resilience in evolving markets.
“With the expansion of R&D and the integration of CMS expertise, we can rapidly advance our product offerings to meet the high demands of the pharmaceutical industry,” said Wayne Tupuola, CEO of LPC. “Our focus on precision and efficiency is transforming drug delivery systems, ensuring optimal performance and patient safety. We are committed to driving forward the future of pharmaceutical manufacturing with cutting-edge solutions that enhance patient outcomes and streamline production processes.”
Comments powered by CComment